Bioxcel Therapeutics Inc (BTAI)

Jan 21, 2025

Why BioXcel Therapeutics Shares Are Rising Tuesday - MSN

Jan 21, 2025

Jan 18, 2025

BioXcel Therapeutics expands board, appoints new director - MSN

Jan 18, 2025

Jan 18, 2025

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Sees Large Drop in Short Interest - Defense World

Jan 18, 2025

Jan 17, 2025

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Shares Sold by Jane Street Group LLC - Defense World

Jan 17, 2025

Jan 16, 2025

Bioxcel Therapeutics Appoints Dr. Rajiv Patni to Board - TipRanks

Jan 16, 2025

Jan 14, 2025

Thinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin? - Marketscreener.com

Jan 14, 2025

Jan 12, 2025

BioXcel Therapeutics files to sell 5.1M shares of common stock by selling shareholders - MSN

Jan 12, 2025

Jan 10, 2025

BioXcel Therapeutics Amends Employment Agreements for Executives - Defense World

Jan 10, 2025

Jan 09, 2025

BioXcel Therapeutics (NASDAQ:BTAI) Earns “Underperform” Rating from Bank of America - Defense World

Jan 09, 2025

Jan 08, 2025

BioXcel Therapeutics amends executive compensation - Investing.com

Jan 08, 2025

Jan 08, 2025

BioXcel Therapeutics amends executive compensation By Investing.com - Investing.com UK

Jan 08, 2025

Jan 08, 2025

Top execs at New Haven-based BioXcel face compensation reductions amid company’s financial struggles - Hartford Business Journal

Jan 08, 2025

Jan 08, 2025

Are Investors Keen On Selling Holdings In BioXcel Therapeutics Inc (NASDAQ: BTAI)? - Stocks Register

Jan 08, 2025

Jan 08, 2025

Bioxcel Therapeutics Revises Executive Compensation Structure - TipRanks

Jan 08, 2025

Jan 07, 2025

BioXcel Therapeutics (NASDAQ:BTAI) Price Target Lowered to $5.00 at Canaccord Genuity Group - Defense World

Jan 07, 2025

Jan 05, 2025

State Street Corp Sells 47,600 Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) - Defense World

Jan 05, 2025

Dec 23, 2024

BioXcel Therapeutics (BTAI) Moves to Buy: Rationale Behind the Upgrade - MSN

Dec 23, 2024

Dec 21, 2024

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Shares Sold by BNP Paribas Financial Markets - Defense World

Dec 21, 2024

Dec 18, 2024

Bioxcel therapeutics CEO sells shares worth $1,131 By Investing.com - Investing.com South Africa

Dec 18, 2024

Dec 18, 2024

Bioxcel therapeutics CFO Richard Steinhart sells $206 in stock By Investing.com - Investing.com Nigeria

Dec 18, 2024

Dec 17, 2024

Bioxcel therapeutics executive sells $153 in stock By Investing.com - Investing.com Australia

Dec 17, 2024

Dec 17, 2024

Bioxcel therapeutics' chief scientific officer sells $151 worth of stock By Investing.com - Investing.com Canada

Dec 17, 2024

Dec 17, 2024

Bioxcel therapeutics CFO Richard Steinhart sells $206 in stock - Investing.com India

Dec 17, 2024

Dec 17, 2024

Bioxcel therapeutics executive sells $153 in stock - Investing.com

Dec 17, 2024

Dec 17, 2024

Bioxcel therapeutics CEO sells shares worth $1,131 - Investing.com

Dec 17, 2024

Dec 17, 2024

Bioxcel therapeutics exec sells $58 in stock By Investing.com - Investing.com UK

Dec 17, 2024

Dec 16, 2024

BioXcel Therapeutics stock hits 52-week low at $0.35 - Investing.com India

Dec 16, 2024

Dec 16, 2024

BioXcel Therapeutics stock hits 52-week low at $0.35 By Investing.com - Investing.com Nigeria

Dec 16, 2024

Dec 05, 2024

BioXcel Therapeutics (STU:BX2) 5-Day RSI : 7.74 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024

Dec 05, 2024

BioXcel Therapeutics stock hits 52-week low at $0.4 By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 04, 2024

BioXcel Therapeutics stock hits 52-week low at $0.4 - Investing.com India

Dec 04, 2024

Nov 25, 2024

BioXcel Therapeutics announces pricing of $7M public offering - MSN

Nov 25, 2024

Nov 23, 2024

BioXcel Therapeutics stock hits 52-week low at $0.5 By Investing.com - Investing.com Australia

Nov 23, 2024

Nov 22, 2024

BioXcel Therapeutics Prices of $7 Million Public Offering - citybiz

Nov 22, 2024

Nov 22, 2024

BioXcel Therapeutics stock hits 52-week low at $0.5 - Investing.com India

Nov 22, 2024

Nov 22, 2024

BioXcel Therapeutics announces $7M public offering - Hartford Business Journal

Nov 22, 2024

Nov 22, 2024

BioXcel Prices New Offering - Baystreet.ca

Nov 22, 2024

Nov 22, 2024

BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering - GlobeNewswire

Nov 22, 2024

Nov 22, 2024

BioXcel Therapeutics Announces $7M Public Offering at $0.48 Per Share with Warrants | BTAI Stock News - StockTitan

Nov 22, 2024